KRAS and lung cancer: In an analysis of infiltrated immune cells in subtypes of lung cancer, researchers found that LUADs with K-ras or EGFR mutations were more densely infiltrated by cells of myeloid lineage, whereas small cell lung cancers (SCLCs) were mostly infiltrated by T cells.